Becker E M, Wunder F, Kast R, Robyr C, Hoenicka M, Gerzer R, Schröder H, Stasch J P
Institute of Cardiovascular and Arteriosclerosis Research, Bayer AG, Wuppertal, Germany.
Nitric Oxide. 1999;3(1):55-66. doi: 10.1006/niox.1999.0207.
A stably transfected soluble guanylate cyclase (sGC, alpha1 and beta1 subunits of the rat lung enzyme)-overexpressing CHO cell line was generated for the characterization of different types of activators of the soluble guanylate cyclase. Polyclonal antibodies directed against both subunits of the rat enzyme were used to detect both subunits in the cytosol of the transfected CHO cells. We studied the effects of different nitric oxide (NO) donors like SNP and DEA/NO and, in particular, the direct, NO-independent stimulator of the soluble guanylate cyclase 3-(5'-hydroxymethyl-2'furyl)-1-benzyl indazole (YC-1), on intracellular guanosine 3',5'-cyclic monophosphate (cGMP) production. DEA/NO (0.01-3 microM), SNP (1-10 microM), and YC-1 (1-10 microM) induced a concentration-dependent intracellular cGMP increase with maximal effects of 16-fold (3 microM DEA/NO), 8-fold (10 microM SNP), and 6-fold (10 microM YC-1) stimulation compared to controls, respectively. In addition, a synergistic effect of the combination of the NO donor and YC-1 could be observed with a maximal stimulation of 64-fold by SNP (10 microM) and YC-1 (10 microM). 1H-(1,2,4)-Oxadiazolo-(4,3-a)-6-bromo-quinoxazin-1-one (ODQ, 10 microM), a potent and selective inhibitor of sGC, inhibited both the single effects of NO donors [DEA/NO (3 microM), 77%; SNP (3 microM), 83%] and YC-1 [YC-1 (3 microM), 82%], but moreover the synergistic effects between NO donors and YC-1 [DEA/NO (3 microM) + YC-1 (3 microM), 81%; SNP (3 microM) + YC-1 (3 microM),89%] on intracellular cGMP production. In summary,we have generated a simple, sensitive, and useful bioassay method to characterize all types of sGC activators on the cellular level without the need of primary cell culture, several transfections, or purifying enzyme from biological materials.
为了鉴定可溶性鸟苷酸环化酶(sGC,大鼠肺酶的α1和β1亚基)不同类型的激活剂,构建了稳定转染的过表达sGC的CHO细胞系。使用针对大鼠酶两个亚基的多克隆抗体来检测转染的CHO细胞胞质溶胶中的两个亚基。我们研究了不同一氧化氮(NO)供体如SNP和DEA/NO的作用效果,特别是可溶性鸟苷酸环化酶的直接、不依赖NO的刺激剂3-(5'-羟甲基-2'呋喃基)-1-苄基吲唑(YC-1)对细胞内3',5'-环磷酸鸟苷(cGMP)产生的影响。DEA/NO(0.01 - 3 microM)、SNP(1 - 10 microM)和YC-1(1 - 10 microM)均诱导细胞内cGMP浓度依赖性增加,与对照组相比,最大效应分别为16倍(3 microM DEA/NO)、8倍(10 microM SNP)和6倍(10 microM YC-1)刺激。此外,可观察到NO供体与YC-1联合使用具有协同效应,SNP(10 microM)和YC-1(10 microM)联合使用时最大刺激可达64倍。1H-(1,2,4)-恶二唑并-(4,3-a)-6-溴喹喔啉-1-酮(ODQ,10 microM),一种有效的sGC选择性抑制剂,既能抑制NO供体的单一作用[DEA/NO(3 microM),抑制77%;SNP(3 microM),抑制83%]和YC-1的单一作用[YC-1(3 microM),抑制82%],还能抑制NO供体与YC-1之间的协同作用[DEA/NO(3 microM) + YC-1(3 microM),抑制81%;SNP(3 microM) + YC-1(3 microM),抑制89%]对细胞内cGMP产生的影响。总之,我们建立了一种简单、灵敏且有用的生物测定方法,无需原代细胞培养、多次转染或从生物材料中纯化酶,即可在细胞水平上鉴定所有类型的sGC激活剂。